Iovance Biotherapeutics, Inc.

📍 San Carlos, United States🗓 Founded 2007👥 922 employees💰 Last funded May 2025
Biotechnology Research🌐 iovance.com
Website LinkedIn
Iovance Biotherapeutics (NASDAQ: IOVA) aims to be the global leader in innovating, developing and delivering tumor infiltrating lymphocyte (TIL) therapies for patients with cancer. We are pioneering a transformational approach to cure cancer by harnessing the human immune system’s ability to recognize and destroy diverse cancer cells in each patient. The Iovance TIL platform has demonstrated promising clinical data across multiple solid tumors. We are committed to continuous innovation in cell therapy, including gene-edited cell therapy, that may extend and improve life for patients with cancer. We are adding to our talented team as we execute our commercial launch, advance our research and development efforts, and build our internal manufacturing capabilities. Iovance is headquartered in the San Francisco Bay Area. Our Iovance Cell Therapy Center (iCTC), a state-of-the-art manufacturing facility, is located in Philadelphia. We also have a research site in Tampa, Florida. Any information expressed by Iovance is subject to the risk factors and information on forward-looking statements contained in its filings with the Securities and Exchange Commission and available here: https://ir.iovance.com/sec-filings
4
Total investors
0
Early stage
0
Mid stage
0
Late stage
2007
Founded

Investors

4 investors
All
Early stage
Mid stage
Late stage
Investor geography3 countries
United States
2
Netherlands
1
France
1
Investor activity2017–2025 · investors recorded per year
20171201912023120251
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Iovance Biotherapeutics, Inc.?
Iovance Biotherapeutics, Inc. has 4 investors on record on gritt.io.
When did Iovance Biotherapeutics, Inc. last raise funding?
The most recent investment in Iovance Biotherapeutics, Inc. recorded on gritt.io was in May 2025.
When was Iovance Biotherapeutics, Inc. founded?
Iovance Biotherapeutics, Inc. was founded in 2007.
What industry is Iovance Biotherapeutics, Inc. in?
Iovance Biotherapeutics, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Iovance Biotherapeutics, Inc. based?
Iovance Biotherapeutics, Inc. is headquartered in San Carlos, United States.